CLDN18 and metastatic malignant neoplasm in the lymph nodes: After Bonferroni correction for multiple comparisons, CLDN18.2-positive tumors still trended towards less invasive growth (pT2+, p = 0.06) and less lymph node metastasis (p = 0.07).